platinum has been researched along with elesclomol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasinoff, BB; Patel, D; Wu, X; Yadav, AA | 1 |
| Ding, Y; Liu, B; Lu, L; Zheng, P; Zhou, C | 1 |
1 review(s) available for platinum and elesclomol
| Article | Year |
|---|---|
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.
Topics: Copper; Humans; Hydrazines; Ionophores; Neoplasms; Platinum; Proteasome Inhibitors | 2022 |
1 other study(ies) available for platinum and elesclomol
| Article | Year |
|---|---|
Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II).
Topics: Antineoplastic Agents; Ascorbic Acid; Cations, Divalent; Cell Survival; Coordination Complexes; Copper; Crystallography, X-Ray; Humans; Hydrazines; K562 Cells; Kinetics; Models, Molecular; Nickel; Oxidation-Reduction; Platinum; Reactive Oxygen Species; Trientine | 2013 |